Study finds common dietary supplement can flush out toxic forever chemicals from your body
Eating a fibre supplement derived from oats before each meal could flush out toxic forever chemicals from the body, a new study suggests.
Per and polyfluoroalkyl substances, or PFAS, commonly known as forever chemicals, are widely used to make products like non-stick cookware, cosmetics, stain-resistant fabrics, firefighting foams, food packaging, and waterproof clothing.
They persist in the environment for hundreds of years and are increasingly linked to a range of health conditions in humans, including decreased fertility, developmental delays in children, and a higher risk of some cancers.
Scientists have been seeking ways to remove them from the body and the environment or degrade them into harmless compounds.
'Despite the growing concerns about the toxicity of PFAS, specific interventions to reduce PFAS levels in the body are limited,' the study notes. 'Current clinical treatments to reduce PFAS body burden are minimal.'
Previous studies have shown that beta-glucan fibre molecules found in oats, barley and rye can bind to PFAS in the digestive system.
The latest study, published in Environmental Health, finds that consuming a dietary supplement with beta-glucan fibre could significantly reduce PFAS levels in the body.
Researchers recruited 72 Canadian men aged 18 to 65 with detectable levels of PFAS in their blood and fed 42 of them a diet supplement of one gram of oat beta-glucan, a type of soluble gel-forming fibre, before each mealtime, when the body produced the most bile.
The remaining 30 participants received a placebo made of rice.
'Serum samples were collected from 72 participants in 2019-2020 at baseline and after four weeks of the intervention and were analysed for 17 PFASs,' the study states.
After four weeks, researchers found a nearly 10 per cent drop in two of the most dangerous PFAS types in people who took the oat fibre supplement. The two forever chemicals, known as PFOA and PFOS, have been detected in drinking water, food packaging and cosmetics, and they can build up in the body over time.
Although the results are modest, scientists say the findings offer a first step to formulating a dietary intervention for removing PFAS from the body.
'Results from this pilot analysis suggest a potentially practical and feasible intervention that may reduce human body burdens for some PFASs,' they say.
'However, studies utilising a larger sample with a broader range of serum concentrations, longer intervention period and clinically relevant fibre intakes are needed to determine the efficacy of using gel-forming dietary fibres to increase PFAS excretion.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Independent
an hour ago
- The Independent
ADHD diagnoses haven't increased ‘that much' despite more seeking an assessment
The number of people with attention deficit hyperactivity disorder (ADHD)"probably isn't increasing that much", researchers have suggested, despite a "marked uptick" in people seeking assessment for the condition. Experts said that while there has been a rise in people being diagnosed with ADHD in the UK, the exact number is "still probably lower than the best estimates" of the true number who have the condition. An increase in patients seeking assessments could possibly be down to greater awareness and less stigma, or disruption caused by the Covid-19 pandemic. Researchers also suggest spending a lot of time online could be creating a "distracted generation", but that it is too early to draw conclusions. And while there is a link between social media and ADHD symptoms it is unclear "what's driving what". ADHD assessments are reported to be increasingly in demand, researchers said, which is putting a strain on health and education systems across the world. People with the neuro-developmental disorder may have trouble concentrating or sitting still, while other symptoms include being easily distracted, forgetfulness, finding it hard to follow instructions or organise time, and making impulsive decisions. Earlier this month, NHS England estimated for the first time that 2,498,000 people in England may have ADHD, which includes those without a diagnosis. Of the total, an estimated 741,000 are children and young people aged five to 24. And more than half a million people (549,000) were waiting for an ADHD assessment at the end of March 2025, up from 416,000 a year earlier, according to figures. The study, led by King's College London, aimed to update reviews on ADHD prevalence by examining global research from 2020 onwards. Academics looked at more than 9,000 studies, with 40 from across 17 different countries - one of which included data from 42 countries - included in the final analysis. Professor Philip Shaw, director of the King's Maudsley Partnership for Children and Young People at KCL's institute of psychiatry, psychology and neuroscience, said: "It seems that our best evidence suggests that the true rate of ADHD probably isn't increasing that much. "However, it's absolutely crystal clear that there is an increase in the number of people who are being clinically recognised or diagnosed as having ADHD in the United Kingdom. "However, I will note that that rate is still probably lower than the best estimates we have of the rate of true ADHD in the population." Dr Alex Martin, a lecturer in psychology and pandemic preparedness at KCL's institute of psychiatry, psychology and neuroscience, added: "What we did find was that ADHD prevalence in adults and children has remained largely stable since 2020." She said that some data being published is "very much out of date", adding: "This causes problems for healthcare policy makers internationally and means that services which are already under pressure may encounter increased demand without receiving additional support. According to Prof Shaw, the health service is "playing catch-up" when it comes to ADHD, which he said could explain "a marked uptick in the numbers of people seeking assessment". Edmund Sonuga-Barke, a professor of developmental psychology, psychiatry and neuroscience at KCL, added there has been "chronic under-recognition" in the history of ADHD, especially for certain groups and in particular women and girls. "So part of the increase in diagnosis we've seen over the last 10 or so years is really a resetting or a recalibration, or a catch-up," he said. Prof Shaw added: "When I was at medical school and training as a psychiatrist, there was actually very little recognition of ADHD, particularly in young people and adults. "Of course, there's both an increased recognition and - very welcome - less stigma around ADHD, which means that people are increasingly coming forward for assessment, and while we're working through that backlog, there are simply going to be long waiting lists." Some other possibilities which Prof Shaw described as "somewhat less likely" include a change in the threshold of how doctors diagnose ADHD and a shift in the understanding of the condition by children and young people. He added that his "hunch" is that the "huge awareness" of ADHD is "that it's often used as a language of distress". "It's sometimes used, I suspect, the way that children and young people are expressing that they are struggling, particularly at school, and need help," he said "And of course, when a child is having problems that are impacting their life in a sustained way, they deserve a full mental health assessment. "Even if the final diagnosis doesn't end up being ADHD, we may often, for example, find that this child is struggling with a problem with mood or anxiety." Other societal issues could be driving the increase in assessments, including the disruption caused by the Covid-19 pandemic and the use of social media. Prof Shaw said: "Many of the skills of learning that kids have, how to focus, how to plan, how to organise themselves, has completely throw them out the loop for about two or three years, and this may well play a part in the uptick in the awareness and seeking of help for symptoms of inattention in particular. "Many also point to a possible role for social media and the impacts it might be having on the developing brain. "Now, for ADHD, there's a great degree of interest in the possibility that what's going on, is that the constant dividing of attention and multitasking online is creating, if you like, a distracted generation. "We know there's an association between social media use and some symptoms of ADHD, but we don't know what's driving what, we don't know what's the chicken and what's the egg." Prof Shaw said he has been "struck" by some of his group's research findings into how "variable" ADHD can be. He suggests ADHD "is a dynamic challenge that changes with age". Prof Sonuga-Barke added: "I think the discovery that ADHD is a continuous risk dimension and not a fixed, natural category with clear biological boundaries may help explain why diagnostic rates are sensitive to changes in cultural values and beliefs, and clinical practices, and environmental risk exposures."
The Sun
an hour ago
- The Sun
Common prescription drug prevents heart attack and stroke WITHOUT deadly risk, scientists discover
A COMMON prescription drug has been linked to lower rates of heart attack and stroke - with no increased risk of major bleeding, say scientists. Low-dose aspirin is recommended by the NHS to prevent heart attacks and strokes in people who are at high risk of them. 1 Because aspirin helps to stop your blood from clotting, it can sometimes make you bleed more easily. For example, you may get nosebleeds and bruise more easily, and if you cut yourself, the bleeding may take longer than normal to stop. Now, a study published by The BMJ supports the use of P2Y12 therapy instead of aspirin for long term prevention. Giving the anti-clotting drug to patients with coronary artery disease was associated with lower rates of cardiovascular death, heart attack and stroke compared with traditional aspirin, with no increased risk of major bleeding. P2Y12 inhibitors are usually given to patients alongside aspirin after percutaneous coronary intervention (PCI) - a procedure to widen or unblock a coronary artery to help prevent cardiovascular events. After several months, patients are usually switched from dual therapy (both drugs) to lifelong aspirin, but some trials have suggested a P2Y12 inhibitor may be more effective for long term prevention than aspirin. So in the new study, researchers analysed individual patient data from five randomised clinical trials involving 16,117 patients who were assigned to either a P2Y12 inhibitor or aspirin after completing dual therapy. When they were followed up four years later, P2Y12 inhibitor therapy was associated with a 23 per cent lower risk of an outcome that combined cardiovascular death, heart attack, or stroke, compared with aspirin - with no significance different in major bleeding. When considering outcomes individually, P2Y12 inhibitor therapy reduced heart attacks and stroke compared with aspirin. The researchers said: "Overall, this study supports preferential P2Y12 inhibitor monotherapy prescription over aspirin due to reductions in major adverse cardiac and cerebrovascular events without increasing major bleeding in the medium term." Women vs. Men Heart Attack Symptoms But, they note "medium term efficacy does not necessarily extend lifelong, which is the duration we advise patients to continue these medications". To prevent heart attacks and strokes in patients with coronary artery disease, it's crucial to make lifestyle changes like quitting smoking, exercising regularly, maintaining a healthy weight, and following a balanced diet. Smoking significantly increases the risk of heart disease and stroke, so quitting is recommended. People should aim for at least 150 minutes of moderate-intensity aerobic exercise per week and choose a diet low in saturated and trans fats, high in fibre, fruits, vegetables, and whole grains, and low in salt. If you drink alcohol, you should do so in moderation. And practice relaxation techniques, like deep breathing or yoga, and find healthy ways to copy with stress. Seeing your doctor regularly for screenings and to monitor your heart health. And making sure you get enough sleep (seven to nine hours per night) is important. Various symptoms and warning signs can indicate heart disease, and being aware of them can help in early detection and treatment...
Daily Mail
an hour ago
- Daily Mail
Scientists' startling warning popular health drinks flooding our fridges will put you in an early grave
They build muscle and are seen as a convenient on-the-go meal. But new research suggests protein shakes could increase your risk of an early death.
